{"id":31364,"date":"2017-11-25T15:25:32","date_gmt":"2017-11-25T15:25:32","guid":{"rendered":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/root\/deti-a-dorast\/konferencie\/athero-prevent2016\/"},"modified":"2023-08-10T12:29:22","modified_gmt":"2023-08-10T11:29:22","slug":"athero-prevent2016","status":"publish","type":"cpt_klinika","link":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/deti-a-dorast\/konferencie\/athero-prevent2016\/","title":{"rendered":"ATHERO-PREVENT"},"content":{"rendered":"
Medzin\u00e1rodn\u00e9 symp\u00f3zium <\/strong><\/p>\n Pod z\u00e1\u0161titou prezidentky sekcie pre ateroskler\u00f3zu SSKB<\/em>, <\/strong>prednostky Klinika det\u00ed a dorastu UPJ\u0160 LF a DFN Ko\u0161ice doc. MUDr. Ingrid Schusterovej, <\/em><\/strong><\/p>\n Cie\u013eom konferencie bolo pouk\u00e1za\u0165 na d\u00f4le\u017eitos\u0165 stratifik\u00e1cie nielen tradi\u010dn\u00fdch rizikov\u00fdch faktorov, ale tie\u017e netradi\u010dn\u00fdch rizikov\u00fdch faktorov a biomarkerov kardiovaskul\u00e1rnych ochoren\u00ed<\/p>\n v dospelej ako aj detskej popul\u00e1cii, a jeho implement\u00e1cie v na\u0161ich podmienkach.<\/p>\n \u010cestn\u00fdm hos\u0165om podujatia bol Professor Richard L. Atkinson, MD<\/em> z USA (<\/em><\/strong>Past President NAASO, ASCN, & the American Obesity <\/em><\/p>\n a triacylglycerolov u Adv36 s\u00e9ropozit\u00edvnych jedincov. Ovplyvnenie infekcie Adv36 m\u00f4\u017ee byt rie\u0161en\u00edm probl\u00e9mu, ktor\u00fd predstavuje jednu zo z\u00e1va\u017en\u00fdch zdravotn\u00edckych prior\u00edt v glob\u00e1lnom, eur\u00f3pskom i celo\u0161t\u00e1tnom meradle.<\/p>\n Za uplynul\u00fdch 10 rokov viacer\u00e9 v\u00fdskumn\u00e9 centr\u00e1 r\u00f4znych \u0161t\u00e1toch sveta za\u010dali sledova\u0165 prevalenciu infekcie Adv36, a jej s\u00favislos\u0165 s obezitou, Ko\u0161ice je jedna z nich. Na<\/p>\n Klinike det\u00ed a dorastu LF UPJ\u0160 a DFN v Ko\u0161iciach<\/em>, pod z\u00e1\u0161titou prednostky<\/em>, doc. MUDr. Ingrid Schusterovej, PhD. <\/strong>prebieha v\u00fdskum zameran\u00fd na spom\u00ednan\u00fa<\/p>\n problematiku.<\/p>\n Doc. MUDr. Ingrid Schusterova, PhD. a <\/em><\/strong>MUDr. Al\u017ebeta T\u00f3h\u00e1tyov\u00e1, PhD<\/em><\/strong>. (Ko\u0161ice) prezentovali v\u00fdsledky spom\u00ednan\u00e9ho<\/p>\n v\u00fdskumu, ktor\u00fd bol zameran\u00fd na \u00falohu netradi\u010dn\u00fdch rizikov\u00fdch faktorov v patogen\u00e9ze obezity a kardiovaskul\u00e1rnych zmien. RNDr.<\/em><\/strong> J\u00e1n Kir\u00e1ly, PhD <\/em><\/strong>(Ko\u0161ice) vo<\/p>\n svojej predn\u00e1\u0161ke sa venoval ADv36 z poh\u013eadu virol\u00f3ga. <\/em><\/p>\n I. ro\u010dn\u00edk medzin\u00e1rodn\u00e9ho symp\u00f3zia, Athero-prevent<\/em> hostil<\/em> aj v\u00fdznamn\u00fdch \u010desk\u00fdch odborn\u00edkov, prof. MUDr. Josefa Hy\u00e1neka, DrSc. <\/em>(\u010cR), <\/em><\/p>\n zdvoraznila \u00falohu kyseline stearovej v metabolizme PUFA. <\/em><\/p>\n S\u00fa\u010das\u0165ou programu symp\u00f3zia bol aj krst knihy doc. MUDr. Jozef Koll\u00e1r, DrSc.<\/em>: Aterotromb\u00f3za, patofyziol\u00f3gia a epidemiol\u00f3gia<\/em>, profesor vo svojej \u010destnej predn\u00e1\u0161ke<\/p>\n pouk\u00e1zal na d\u00f4le\u017eitos\u0165 cholesterolu z glob\u00e1lneho poh\u013eadu metabolizmu.<\/em><\/p>\n O vz\u0165ahu mikrobiomu ku obezite <\/em>hovor\u00ed Doc. MUDr. Mil\u00e1n Kuchta, CSc, mim prof. <\/em><\/strong>(Ko\u0161ice), prezident SPS.<\/strong><\/p>\n MUDr<\/strong><\/em>. Pavol \u0160imurka<\/em><\/em>, PhD.<\/em><\/strong> (Tren\u010d\u00edn) vo svojom prejave poukazuje na d\u00f4le\u017eitos\u0165 celoplo\u0161n\u00e9ho sck\u00edningu <\/em><\/p>\n Na tomto f\u00f3re odborn\u00edci z Kliniky det\u00ed a dorastu LF UPJ\u0160 a DFN v Ko\u0161iciach, z Fakulty humanitn\u00fdch a pr\u00edrodn\u00fdch vied, Pre\u0161ovskej Univerzity prezentovali svoje sk\u00fasenosti<\/p>\n a v\u00fdsledky.<\/p>\n Dlhodob\u00e9 p\u00f4sobenie kardiovaskul\u00e1rnych rizikov\u00fdch faktorov a epid\u00e9mia detskej obezity zvy\u0161uj\u00fa naliehavos\u0165 prim\u00e1rnej prevencie kardiovaskul\u00e1rnych ochoren\u00ed u\u017e v detskom veku.<\/p>\n","protected":false},"author":1,"featured_media":31365,"parent":31360,"menu_order":0,"template":"","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[],"tags":[],"tax_aktuality":[],"class_list":["post-31364","cpt_klinika","type-cpt_klinika","status-publish","has-post-thumbnail","hentry"],"acf":{"acf_link_na_externy_obsah":""},"yoast_head":"\n
\n<\/em><\/strong>PhD.<\/em><\/strong> v spolupr\u00e1ci so sekciou prevencie kardiovaskul\u00e1rnych ochoren\u00ed SPS<\/em><\/strong> v Ko\u0161iciach sa dna 5. decembra 2016 uskuto\u010dnil medzin\u00e1rodn\u00e9 symp\u00f3zium- Athero-prevent.<\/p>\n
\n<\/em>Association)<\/em>. V roku 2005, Professor Atkinson ako prv\u00fd v hum\u00e1nnych \u0161t\u00fadi\u00e1ch potvrdil signifikantn\u00e9 spojenie obezity a Adv36 (adenov\u00edrus 36) s\u00e9ropozitivity, ni\u017e\u0161iu koncentr\u00e1ciu cholesterolu<\/p>\n
\n<\/em>MUDr. Evu Tvrzicku <\/em>(\u010cR) . <\/em>Predn\u00e1\u0161ka prof. MUDr. Hyaneka bola zameran\u00e1 na necholesterolov\u00e9 steroly v tehotenstve u zdrav\u00fdch<\/em>, <\/em>MUDr.. Tvrzick\u00e1 vo svojej predn\u00e1\u0161ke<\/p>\n
\n<\/em>cholesterolu na Slovensku, a jeho \u00falohe v p<\/em>rim\u00e1rnej prevencia ateroskler\u00f3zy v detskom veku.<\/em><\/p>\n